Amir Inamdar

Amir Inamdar is a qualified psychiatrist and pharmaceutical physician with over 20 years of clinical and drug development experience. He successfully progressed numerous candidate drugs through preclinical development and early phase clinical trials to proof-of-concept studies. Amir has experience in leading global teams overseeing the development of novel medications across a range of psychiatric indications including treatment-resistant depression, narcolepsy, anxiety, schizophrenia, bipolar disorder, and substance use disorders.